CN Patent

CN102249935B — 芳香2-丁醇类化合物及其医药用途

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2015-05-20 · 11y expired

What this patent protects

本发明涉及新型芳香2-丁醇类化合物及其医药用途。具体地说，本发明涉及式I化合物，及其光学异构体、消旋体、非对映异构体、药学可接受的盐、溶剂合物：其中各取代基的定义如说明书所述。本发明还涉及包含所述化合物的药物组合物、以及所述化合物在制备用于治疗和/或预防与结核杆菌感染有关的疾病或病症的药物中的用途。本发明式I化合物可以有益地治疗和/或预防与结核杆菌感染有关的疾病或病症。

USPTO Abstract

本发明涉及新型芳香2-丁醇类化合物及其医药用途。具体地说，本发明涉及式I化合物，及其光学异构体、消旋体、非对映异构体、药学可接受的盐、溶剂合物：其中各取代基的定义如说明书所述。本发明还涉及包含所述化合物的药物组合物、以及所述化合物在制备用于治疗和/或预防与结核杆菌感染有关的疾病或病症的药物中的用途。本发明式I化合物可以有益地治疗和/或预防与结核杆菌感染有关的疾病或病症。

Drugs covered by this patent

bedaquiline-fumarate (BEDAQUILINE FUMARATE)

Patent Metadata

Patent number: CN102249935B
Jurisdiction: CN
Classification: —
Expires: 2015-05-20
Drug substance claim: No
Drug product claim: No
Assignee: Institute of Pharmacology and Toxicology of AMMS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.